Literature DB >> 24392257

Treatment of hyperprolactinemia and gynecomastia with adjunctive aripiprazole in 2 men receiving long-acting injectable antipsychotics.

Douglas L Boggs1, Mohini Ranganathan1, Angela A Boggs1, Christine M Bihday1, Barbara E Peluse1, Deepak C D'Souza1.   

Abstract

Entities:  

Year:  2013        PMID： 24392257      PMCID： PMC3869609          DOI： 10.4088/PCC.13l01519

Source DB:  PubMed          Journal:  Prim Care Companion CNS Disord        ISSN： 2155-7780


× No keyword cloud information.
  7 in total

1.  Preliminary report: a naturalistic study of the effect of aripiprazole addition on risperidone-related hyperprolactinemia in patients treated with risperidone long-acting injection.

Authors:  Marcel van Kooten; Johannes Arends; Dan Cohen
Journal:  J Clin Psychopharmacol       Date:  2011-02       Impact factor: 3.153

2.  Using aripiprazole to resolve antipsychotic-induced symptomatic hyperprolactinemia: a pilot study.

Authors:  Bun-Hee Lee; Yong-Ku Kim; Sun-Hwa Park
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2006-03-29       Impact factor: 5.067

3.  Prolactin levels and adverse events in patients treated with risperidone.

Authors:  D L Kleinberg; J M Davis; R de Coster; B Van Baelen; M Brecher
Journal:  J Clin Psychopharmacol       Date:  1999-02       Impact factor: 3.153

4.  Dose-dependent effects of adjunctive treatment with aripiprazole on hyperprolactinemia induced by risperidone in female patients with schizophrenia.

Authors:  Norio Yasui-Furukori; Hanako Furukori; Norio Sugawara; Akira Fujii; Sunao Kaneko
Journal:  J Clin Psychopharmacol       Date:  2010-10       Impact factor: 3.153

5.  A multicenter, randomized, double-blind, placebo-controlled, 16-week study of adjunctive aripiprazole for schizophrenia or schizoaffective disorder inadequately treated with quetiapine or risperidone monotherapy.

Authors:  John M Kane; Christoph U Correll; Donald C Goff; Brian Kirkpatrick; Stephen R Marder; Estelle Vester-Blokland; Wei Sun; William H Carson; Andrei Pikalov; Sheila Assunção-Talbott
Journal:  J Clin Psychiatry       Date:  2009-10       Impact factor: 4.384

Review 6.  Antipsychotic-induced hyperprolactinaemia: mechanisms, clinical features and management.

Authors:  Peter M Haddad; Angelika Wieck
Journal:  Drugs       Date:  2004       Impact factor: 9.546

7.  Adjunctive treatment with a dopamine partial agonist, aripiprazole, for antipsychotic-induced hyperprolactinemia: a placebo-controlled trial.

Authors:  Joo-Cheol Shim; Jae-Goo K Shin; Deanna L Kelly; Do-Un Jung; Young-Soo Seo; Kwang-Hyeon Liu; Ji-Hong Shon; Robert R Conley
Journal:  Am J Psychiatry       Date:  2007-09       Impact factor: 18.112
  7 in total
  3 in total

Review 1.  Is Adjunct Aripiprazole Effective in Treating Hyperprolactinemia Induced by Psychotropic Medication? A Narrative Review.

Authors:  Frank M C Besag; Michael J Vasey; Iffah Salim
Journal:  CNS Drugs       Date:  2021-04-20       Impact factor: 5.749

2.  Bipolar disorder, comorbid anxiety disorders, gynecomastia and dental pain: case analysis with literature review.

Authors:  Kenneth R Kaufman; Ronke Babalola; Miriam Campeas; Melissa Coluccio
Journal:  BJPsych Open       Date:  2018-04-26

3.  Management of antipsychotic-induced hyperprolactinemia.

Authors:  Ashley Tewksbury; Amy Olander
Journal:  Ment Health Clin       Date:  2016-06-29
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.